Regulatory Open Forum

 View Only
  • 1.  Essential DHF Documentation for Design Control

    This message was posted by a user wishing to remain anonymous
    Posted 10-Aug-2023 09:06
    This message was posted by a user wishing to remain anonymous

    Can anyone advise on the essential DHF documents that must be approved prior to start of design control (product is class II in US)? Per US FDA, design control should start with the approval of design inputs if the business hasn't determined to formally start sooner, correct? I know approved DDP, Risk Management Plan, and Software Development Plan are essential but are there other DHF deliverables that are hard requirements to start? Thoughts or direction on resources welcome. Thank you!



  • 2.  RE: Essential DHF Documentation for Design Control

    Posted 10-Aug-2023 09:56

    Hello  - I don't know of "hard" requirements explicitly stated anywhere.

    From a practical point of view, it would be difficult to explain why we don't have a design and development plan before we begin our work. A risk management plan is part of a parallel effort that should align with your activities during design and development. It is important to plan and start your risk management activities in a timely way so you have a complete list of safety related design inputs. 

    Curious to hear the opinion of other colleagues.



    ------------------------------
    Naveen Agarwal, Ph.D.
    Problem Solver | Knowledge Sharer.
    Let's Talk Risk!
    @https://naveenagarwalphd.substack.com/
    ------------------------------



  • 3.  RE: Essential DHF Documentation for Design Control

    Posted 10-Aug-2023 10:06

    A key factor is that FDA design control requirements don't apply to the research and concept phase.  Think "R" of R&D.  But once we reach the "D" step, design controls generally apply. FDA says that design control begins with development and approval of design inputs.  FDA tells us to document the flow of the design process so that it is clear to the FDA investigator where research is ending and development of the design is beginning.  Accordingly, the general expectation is that once a concept is proven, then the firm's "official" statement of its intent to pursue development is the first required document to begin design controls and thus the first required document for your DHF.  Your design control procedures should incorporate these principles and practices.



    ------------------------------
    Kevin Randall, ASQ CQA, RAC (U.S., Europe, Canada)
    Principal Consultant
    Ridgway, CO
    United States
    © Copyright 2023 by ComplianceAcuity, Inc. All rights reserved.
    ------------------------------



  • 4.  RE: Essential DHF Documentation for Design Control

    Posted 10-Aug-2023 10:18

    Regarding the design plan: We certainly are required to have that before we begin our work as Naveen says.  And FDA's statement about when design controls start (approval of design inputs) can be misleading because the design plan needs to be approved before going into the design input phase.  Ultimately, a general chronology of document completion (and thus DHF records) is:

    • Concept phase [Not required by the design control regulation but should be part of your SOP and thus should be made mandatory by way of SOP.  The systems I build prescribe a Product Concept Document (PCD)].
    • Design Initiation Authorization (DIA) form
    • Design Plan record and approval
    • Design Inputs record and approval
    • And so on that is beyond the scope of this post.


    ------------------------------
    Kevin Randall, ASQ CQA, RAC (U.S., Europe, Canada)
    Principal Consultant
    Ridgway, CO
    United States
    © Copyright 2023 by ComplianceAcuity, Inc. All rights reserved.
    ------------------------------



  • 5.  RE: Essential DHF Documentation for Design Control

    Posted 14-Aug-2023 07:39

    Good Day Anon...

     

    We have used 2 resources from the FDA, while they are dated, they still provide valuable information:

     

    From CDRH – Design Control Guidance for Medical Device Manufacturers

     

    FDA QSR Manual – Section 3. Desing Controls.

     

    Hope these help!

     

    D. Michelle Williams, CESCO

    VP – Operations

     

    Action Products, Inc.

    www.actionproducts.com

    301.797.1414 X1022

     

    https://www.linkedin.com/in/dmwilliamsvpopapiwvu88

     

     

    Action-MMD-Ribbon_Logo_5in_cmyk